Adjuvant Global Health Technology Fund, L.P.
Shareholder at ANTX
- Sold, on record
- $1.7M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Oct 2, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ANTXAN2 Therapeutics, Inc.Shareholder
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ANTXNo planSep 13, 2023 2023
Sold 400 shares at $16.00 ($6k)
Adjuvant Global Health Technology Fund, L.P., 10% owner
No 10b5-1 planSold 0% of holdings ($34.8M position)2.2M shares leftFirst sale on recordFiling
- 2 Form 4 sale ANTXNo planOct 2, 2023 +19 days
Sold 104,773 shares at $16.27 ($1.7M)
Adjuvant Global Health Technology Fund, L.P., 10% owner
No 10b5-1 planSold 4.8% of holdings ($35.6M position)2.1M shares leftFiling
- 3 Form 144 notice ANTXNoticeJan 16, 2024 +106 days
Filed to sell 84,093 shares ($1.8M)
Adjuvant Global Health Technology Fund, L.P., Shareholder
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 16, 2024 | Jan 16, 2024 | ANTX | Shareholder | Form 144 notice | 84,093 | $1.8M | Notice | SEC | |
| Oct 2, 2023 | Oct 3, 2023 | ANTX | 10% owner | Form 4 sale | 104,773 | $1.7M | 4.8% | No plan | SEC |
| Sep 13, 2023 | Sep 15, 2023 | ANTX | 10% owner | Form 4 sale | 400 | $6k | 0.0% | No plan | SEC |